EVH (Health Care Technology) Stock Valuation & Fair Value Fairly valued
EVH (Health Care Technology) trades at a blended P/E of 21.6, about 38% below its historical normal valuation, with a forward growth estimate of 55.6% and a PEG of 0.39. Analysts' one-year estimates have been hit 10% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is EVH overvalued?
At a blended P/E of 21.6 versus its historical normal P/E of 34.9, EVH trades about 38% below its typical valuation, with a PEG of 0.39 on 55.6% forward growth. tickerseer currently rates it fairly valued.
What is EVH's fair value and PEG?
EVH trades at a blended P/E of 21.6 against a historical normal P/E of 34.9, a PEG of 0.39, and a forward growth estimate of 55.6%.
Has tickerseer's rating of EVH changed?
tickerseer's rating has been fairly valued since 2026-07-31.
Industry: Health Care Technology. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.